BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farid K, Elalfy H, Abo El-Khair SM, Elgamal H, Besheer T, Elmokadem A, Shabana W, Abed S, Elegezy M, El-Khalek AA, El-Morsy A, Negm A, Elsamanoudy AZ, El Deek B, Amer T, El-Bendary M. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients. Expert Rev Gastroenterol Hepatol 2020;14:1203-14. [PMID: 32933325 DOI: 10.1080/17474124.2020.1823215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao GS, Liu S, Liu Y, Li C, Wang RY, Bian J, Zhang YW, Zhou J, Lin YJ, Wu J. Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study. Expert Rev Gastroenterol Hepatol 2022;:1-8. [PMID: 35709813 DOI: 10.1080/17474124.2022.2091545] [Reference Citation Analysis]
2 Neamatallah M, Serria MS, El‐bendary M, El‐gilany A, Alhawarey A, Abed S, Setate YA, Ammar OA. Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome. Br J Biomed Sci 2022;79:10237. [DOI: 10.3389/bjbs.2021.10237] [Reference Citation Analysis]
3 Farid K, Elalfy H, El-bendary M, Besheer T, El-eraky A, Abdelbadie M, Elmokadem A, Moawad A, El-khair SA, Sakr S, El-deek B, El-morsy A, Elmorsy RA, Amer T, Abed S. Cardiopulmonary assessment of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization. Journal of Liver Transplantation 2022;5:100063. [DOI: 10.1016/j.liver.2021.100063] [Reference Citation Analysis]
4 Ouyang T, Liu J, Shi C, Zhu L, Guo X. Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study. J Hepatocell Carcinoma 2021;8:1459-71. [PMID: 34858890 DOI: 10.2147/JHC.S338309] [Reference Citation Analysis]
5 Li H, Wang M, Chen P, Li F, Kuang D, Han X, Ren J, Duan X. Occurrence, Related Factors and Prognostic Value of Vascular Lake in Hepatocellular Carcinoma Patients Treated with Drug-Eluting Bead Transarterial Chemoembolization. Onco Targets Ther 2021;14:4659-70. [PMID: 34511935 DOI: 10.2147/OTT.S297523] [Reference Citation Analysis]
6 Zhang W, Chen L, Cao Y, Sun B, Ren Y, Sun T, Zheng C. Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma. Cancer Manag Res 2021;13:5391-402. [PMID: 34262347 DOI: 10.2147/CMAR.S314762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhou TY, Tao GF, Chen SQ, Wang HL, Zhang YL, Zhou GH, Nie CH, Zhu TY, Wang BQ, Yu ZN, Jing L, Chen F, Sun JH. Complete Response of Hepatocellular Carcinoma with Macroscopic Vascular Invasion and Pulmonary Metastasis to the Combination of Drug-Eluting Beads Transarterial Chemoembolization and Huaier Granule: A Case Report. Onco Targets Ther 2021;14:3873-80. [PMID: 34188493 DOI: 10.2147/OTT.S309660] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Fang YS, Wu Q, Zhao HC, Zhou Y, Ye L, Liu SS, Li XX, Du WD. Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis. Expert Rev Gastroenterol Hepatol 2021;15:1065-76. [PMID: 33691550 DOI: 10.1080/17474124.2021.1900731] [Cited by in F6Publishing: 2] [Reference Citation Analysis]